Cargando…
Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
BACKGROUND: A growing number of pharmacological and nonpharmacological trials have been performed to test the efficacy of approved or experimental treatments in Alzheimer disease (AD) and mild cognitive impairment (MCI). In this context, functional magnetic resonance imaging (fMRI) may be a good can...
Autores principales: | Canu, Elisa, Sarasso, Elisabetta, Filippi, Massimo, Agosta, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819240/ https://www.ncbi.nlm.nih.gov/pubmed/29458420 http://dx.doi.org/10.1186/s13195-018-0347-1 |
Ejemplares similares
-
Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks
por: Basaia, Silvia, et al.
Publicado: (2018) -
Brain activity of the emotional circuit in Parkinson’s disease patients with freezing of gait
por: Sarasso, Elisabetta, et al.
Publicado: (2021) -
An update on magnetic resonance imaging markers in AD
por: Leocadi, Michela, et al.
Publicado: (2020) -
Breakdown of the affective‐cognitive network in functional dystonia
por: Canu, Elisa, et al.
Publicado: (2020) -
Action observation training to improve motor function recovery: a systematic review
por: Sarasso, Elisabetta, et al.
Publicado: (2015)